Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?

Biomolecules
Fatma ElrashdyVladimir N Uversky

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing a pandemic of coronavirus disease 2019 (COVID-19). The worldwide transmission of COVID-19 from human to human is spreading like wildfire, affecting almost every country in the world. In the past 100 years, the globe did not face a microbial pandemic similar in scale to COVID-19. Taken together, both previous outbreaks of other members of the coronavirus family (severe acute respiratory syndrome (SARS-CoV) and middle east respiratory syndrome (MERS-CoV)) did not produce even 1% of the global harm already inflicted by COVID-19. There are also four other CoVs capable of infecting humans (HCoVs), which circulate continuously in the human population, but their phenotypes are generally mild, and these HCoVs received relatively little attention. These dramatic differences between infection with HCoVs, SARS-CoV, MERS-CoV, and SARS-CoV-2 raise many questions, such as: Why is COVID-19 transmitted so quickly? Is it due to some specific features of the viral structure? Are there some specific human (host) factors? Are there some environmental factors? The aim of this review is to collect and concisely summarize the possible and logical answers to these questions.

References

Nov 21, 1992·Annals of the New York Academy of Sciences·U FagioloC Franceschi
Jun 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R VlasakP Palese
Jan 1, 1987·Annual Review of Medicine·H Y Reynolds
Jan 1, 1966·Proceedings of the Society for Experimental Biology and Medicine·D Hamre, J J Procknow
Apr 1, 1967·The Journal of General Virology·J D Almeida, D A Tyrrell
Nov 1, 1970·Proceedings of the Society for Experimental Biology and Medicine·M BruckováR M Chanock
Apr 1, 1967·Proceedings of the National Academy of Sciences of the United States of America·K McIntoshR M Chanock
Sep 23, 1967·British Medical Journal·A F BradburneD A Tyrrell
Jan 1, 1980·Journal of Medical Virology·H E LarsonD A Tyrrell
Jul 7, 1983·The New England Journal of Medicine·A J McMichaelP A Beare
Dec 1, 1981·The Journal of Cell Biology·K S MatlinK Simons
Oct 1, 1994·The Journal of Cell Biology·T J WickhamG R Nemerow
Dec 29, 1998·Emerging Infectious Diseases·E DomingoC Escarmís
Jan 20, 1999·Cellular and Molecular Life Sciences : CMLS·C Traving, R Schauer
Jun 30, 2000·Proceedings. Biological Sciences·S Gandon, Y Michalakis
Aug 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·J LeMaoultJ Nikolich-Zugich
Sep 14, 2000·Current Biology : CB·O T Fackler, B M Peterlin
Jan 5, 2002·The Journal of Biological Chemistry·Scott H DonaldsonSherif E Gabriel
Jun 21, 2002·The Journal of General Virology·Sara B Sieczkarski, Gary R Whittaker
Jul 3, 2002·Nature Reviews. Immunology·Raymond M Welsh, Liisa K Selin
Sep 11, 2002·Evolution; International Journal of Organic Evolution·Peter H ThrallJames D Bever
Sep 20, 2002·Journal of Virology·Sara B Sieczkarski, Gary R Whittaker
Mar 14, 2003·Trends in Biochemical Sciences·Mattias Belting
Mar 15, 2003·Science·Peter H Thrall, Jeremy J Burdon
Aug 2, 2003·Current Opinion in Cell Biology·Lucas Pelkmans, Ari Helenius
Sep 11, 2003·Journal of Medical Virology·M L NgA E Ling
Jan 17, 2004·Science·Bryan T GrenfellEdward C Holmes
Mar 11, 2004·Proceedings of the National Academy of Sciences of the United States of America·Graham SimmonsPaul Bates
Mar 23, 2004·Nature Medicine·Lia van der HoekBen Berkhout
Mar 27, 2004·The New England Journal of Medicine·Dongping XuFu-Sheng Wang
Apr 10, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ron A M FouchierAlbert D M E Osterhaus
Apr 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Himani BishtBernard Moss
Apr 28, 2004·Trends in Endocrinology and Metabolism : TEM·Louise M BurrellMark E Cooper
Jun 2, 2004·Journal of Medical Virology·Zhang QinfenZhang Jingqiang
Jun 15, 2004·Journal of Virology·Ciğdem H WilliamsGlyn Stanway
Jul 1, 2004·Arthritis Research & Therapy·Sara A Johnson, John C Cambier
Oct 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Adam L FeireTeresa Compton

❮ Previous
Next ❯

Citations

Sep 24, 2020·American Journal of Human Biology : the Official Journal of the Human Biology Council·Sreedhar Chinnaswamy
Dec 3, 2020·The FEBS Journal·Murat SeyranBruce D Uhal
Feb 6, 2021·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Jatin MachhiBhavesh D Kevadiya
Dec 31, 2020·Pathogens·Deepmala KarmakarSanghamitra Sengupta
Jul 19, 2021·Autoimmunity Reviews·Elrashdy M RedwanVladimir N Uversky
Jul 27, 2021·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Paulina Fuentes-ZacaríasDiana M Morales-Prieto
Aug 27, 2021·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Andrea CacciamaniAlessandra Micera
Sep 1, 2021·Actualités pharmaceutiques·Justine Adnet, Julia Dina

❮ Previous
Next ❯

Methods Mentioned

BETA
bronchoalveolar
scRNA-seq
ubiquitination

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.